What Are Desmoid Tumors?
Desmoid tumors (also called desmoid-type fibromatosis or aggressive fibromatosis) are rare, locally aggressive, non-cancerous growths composed of clonal fibroblastic cells that infiltrate surrounding tissues and have a strong tendency to recur locally but cannot metastasize. 1
Key Defining Characteristics
According to the World Health Organization, desmoid tumors are defined as a "clonal fibroblastic proliferation that arises in the deep soft tissues and is characterized by infiltrative growth and a tendency toward local recurrence but an inability to metastasize" 1. Despite being benign and unable to spread to distant sites, these tumors can cause significant morbidity and occasionally death through local invasion of critical structures 2.
Epidemiology and Demographics
- Incidence: Extremely rare, occurring in only 5-6 cases per 1 million people annually 1
- Peak age: 30-40 years old 1
- Associated conditions: Approximately 5-10% arise in patients with familial adenomatous polyposis (FAP) 1
- Other associations: Pregnancy and Gardner syndrome 2
Clinical Behavior and Natural History
Desmoid tumors exhibit highly variable and unpredictable clinical courses 3. This unpredictability is a defining feature:
- Spontaneous regression occurs in 20-30% of cases, observed at all anatomic sites 1
- Progression-free survival of approximately 50% at 5 years has been documented in asymptomatic patients managed with watchful waiting 1
- Tumors may remain stable, grow slowly, grow rapidly, or spontaneously shrink without treatment
Anatomic Locations and Growth Pattern
Desmoid tumors arise in three main locations, each with slightly different biologic behavior 2:
- Abdominal wall (best prognosis for recurrence)
- Intra-abdominal/mesenteric
- Extremities and trunk (worse prognosis for recurrence)
Macroscopically, tumors appear nodular and bulky but characteristically have tentacle-like spiculated extensions with infiltrative growth along fascial planes 1. They are frequently intermuscular and can be multifocal, usually within the same body part 1.
Symptom Burden and Impact on Quality of Life
The disease carries substantial clinical burden 4:
- Up to 63% of patients experience chronic pain
- 73% report sleep disturbance
- 46% experience irritability
- 15% develop anxiety/depression
- Common symptoms include limited function and mobility, fatigue, muscle weakness, and swelling around the tumor
Overall quality of life is significantly lower than in healthy controls 4.
Molecular Genetics
Nuclear accumulation of β-catenin on immunostaining is characteristic, and activating mutations in CTNNB1 (the gene encoding β-catenin) are confined to desmoid tumors in the differential diagnostic setting 1. β-catenin mutational status correlates with recurrence risk, while surgical margins do not consistently correlate 1.
Diagnostic Challenges
- Diagnosis is challenging due to morphologic heterogeneity and variable clinical presentation 4
- Misdiagnosis rates as high as 30-40% have been reported during initial work-up at some centers 1
- Patients often visit multiple healthcare providers, facing delays in correct diagnosis 4
- Histopathologic confirmation is mandatory before initiating treatment, preferably with core needle biopsy (14G or 16G) rather than incisional or excisional biopsy 1
Important Caveats
- Despite being classified as benign, desmoid tumors can be life-threatening when located at critical sites (e.g., mesentery) due to local invasion 1
- The same-sized tumor may remain asymptomatic in some locations but be life-threatening in others 1
- Low disease awareness among healthcare providers due to rarity contributes to diagnostic delays 4